🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-522726-12-00
Authorised Phase I

Phase 1 study to investigate the pharmacokinetic profile and safety of 3 testosterone gel formulations in postmenopausal female participants.

2025-522726-12-00 · tracked via the Priya Life Science EU tracker
Sponsor
Chemo Research S.L.
Sponsor type
Pharmaceutical company
Therapeutic area
Not possible to specify
Decision date
02/12/2025
Enrollment target
24
Sites
Spain

Condition studied

No medical conditions.

Eligibility

Age group
65+ years, 18-64 years
Sex
Female
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-522726-12-00 on CTIS ↗ ← All trials in the EU